| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | E569WG6E60 |
| InChI Key | MCGDSOGUHLTADD-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C28H29NO4S |
| Molecular Weight | 475.61 |
| AlogP | 6.94 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 51.16 |
| Molecular species | BASE |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 34.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 1
|
0 | 22-42 | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group A
Nuclear hormone receptor subfamily 3 group A member 2
|
- | 66-240 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Osteoporosis, Postmenopausal | 3 | D015663 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Osteoporosis | 2 | D010024 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 182133-25-1 |
| ChEMBL | CHEMBL226267 |
| DrugBank | DB06249 |
| EPA CompTox | DTXSID10171255 |
| FDA SRS | E569WG6E60 |
| PubChem | 179337 |
| SureChEMBL | SCHEMBL285277 |
| ZINC | ZINC000001544683 |